Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
When people first hear about NK cell therapy, the explanation is often hopeful: your own immune cells are strengthened and returned to your body. That description is accurate as far as it goes, but a good decision needs a fuller picture. This article looks at the other side of the question: what the therapy cannot be expected to do, how to read the evidence, and which questions are worth asking before a consultation.
The short answer
NK cell therapy is a cancer immune cell therapy that is not covered by Japan’s public health insurance. It is meant to be considered alongside, not instead of, standard cancer treatment such as surgery, chemotherapy and radiation therapy. Its effects differ from person to person, and the research on it is still developing. Whether it fits your situation is something only a doctor who has examined you and reviewed your medical history can judge.
What the therapy involves
Natural killer (NK) cells are a type of lymphocyte that belongs to the innate immune system. They patrol the body and can recognize and attack abnormal cells, including some cancer cells and virus-infected cells, without waiting for instructions from other immune cells. Researchers have also observed that NK cell activity can decline with age, stress and the effects of cancer itself.
In NK cell therapy, a sample of your own blood is collected through a standard blood draw. At a licensed cell processing facility, NK cells are activated and expanded outside the body. The cells are then returned to you by intravenous infusion. Because your own cells are used, the risk of rejection is considered low, and treatment does not require a hospital stay. The aim is to support immune function that may have weakened, not to replace other treatment.
How to read the evidence
Adoptive transfer of NK cells has been studied in a range of clinical research settings, and a number of early-phase studies have reported that infusing NK cells was feasible and generally tolerated. This is encouraging, but it is not the same as showing that a treatment extends survival. Early-phase studies are usually small, are designed mainly to look at tolerability, and often involve different cell preparation methods, doses and cancer types. Results from one protocol cannot simply be applied to another.
When you come across a claim about NK cell therapy, it helps to ask a few plain questions. Which cancer type and stage were studied? Were the patients also receiving other treatment? How many people took part, and was there a comparison group? Was the outcome a laboratory measurement, such as immune cell activity, or a result that matters directly to patients, such as survival or quality of life? A single study, a personal story or a testimonial is not a reliable basis for a treatment decision, and a responsible clinic will be willing to discuss these limits openly.
Limits and possible side effects to understand
Several limits are worth keeping in mind. First, the effect of NK cell therapy on any individual cannot be predicted in advance. Some tumors are known to evade or suppress NK cells, and the environment around a tumor may reduce the activity of infused cells. Second, the quality and number of cells that can be grown depend on the condition of the blood sample, which can vary with age, previous treatment and overall health. Third, strong evidence from large randomized trials is still limited, so expectations should be measured.
Side effects reported with autologous NK cell infusion have generally been mild, with temporary fever, chills or fatigue being the most commonly described. Serious reactions have rarely been reported, but they cannot be ruled out, and any infusion carries general procedural risks such as discomfort at the needle site. Your doctor should explain these risks, what monitoring is in place, and what to do if symptoms appear after you return home.
Where it fits alongside standard treatment
Standard treatments remain the foundation of cancer care, because they have been tested in larger studies and are supported by clinical guidelines. NK cell therapy does not need to replace any of them. It is described as compatible with surgery, chemotherapy and radiation therapy, and some patients also consider it after treatment with the aim of supporting immune function. The timing relative to chemotherapy or radiation therapy matters, so this should be planned together with your oncologist.
Please do not stop or postpone recommended treatment in order to try an immune cell therapy. If you are already being treated elsewhere, bring your latest test results and a summary of your current plan to the consultation, so that the doctor can consider coordinating with your treating hospital.
Questions to ask in Osaka before you decide
Grand Green Osaka Umekita Clinic in Umeda, Osaka, offers NK cell therapy as a self-pay treatment under Japan’s Act on the Safety of Regenerative Medicine, which requires a treatment plan to be submitted to and accepted by the authorities. Information pages are available in several languages, which can help international patients and residents who are more comfortable in languages other than Japanese. A legal framework does not by itself tell you whether a treatment will help you, so the consultation is the place to ask direct questions.
- Is NK cell therapy appropriate for my cancer type, stage and current treatment?
- What is known, and what is not yet known, about its effect in situations like mine?
- What are the total costs, how many sessions are proposed, and over what period?
- What side effects and risks should I expect, and who can I contact after treatment?
- Can the clinic coordinate with my current hospital and share information with my oncologist?
- If I live abroad, how would follow-up and any problems be handled after I return home?
Because this is not covered by insurance, costs, schedule and eligibility should be confirmed in writing before you agree to anything. If you are traveling for treatment, think through the practical side as well, including visits for blood collection and infusion, interpretation and medical records.
Key takeaways
NK cell therapy uses your own immune cells and has been described as gentle on the body, but it is not a replacement for standard cancer treatment, and its benefits cannot be promised. The most useful way to approach it is with realistic expectations, a clear view of the evidence and a list of specific questions. Costs, risks, side effects and whether you are a suitable candidate need to be confirmed with a doctor after an examination. If you would like to discuss your situation, you can contact Grand Green Osaka Umekita Clinic to arrange a consultation and ask the questions above.
- Alongside standard careNot a replacement
- Read the evidenceCheck study size and type
- Ask about risks and costsSelf-pay, confirm in writing
- Talk with your doctorsCoordinate with your hospital
This diagram summarizes the article as a conceptual overview
References
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.